CStone Pharmaceuticals
Michael Choi is the Chief Business & Strategy Officer at CStone Pharmaceuticals, bringing extensive experience in business development and strategy from their previous roles at Pfizer, Sun Pharma Advanced Research Company Ltd., Life Technologies, and more. Michael is a knowledgeable leader in evaluating and executing strategic transactions, developing commercial business cases, and overseeing operations in various business units. With a strong educational background from Columbia University, Michael has a BA in History & Pre-medical Sciences and an MBA in Finance & Economics from Columbia Business School.
This person is not in any offices
CStone Pharmaceuticals
CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established at the end of 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. With a strategic emphasis on immuno-oncology combination therapies, the Company has built an oncology-focused pipeline of 16 drug candidates, including 5 late-stage candidates at pivotal trials or registration stages. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone’s vision is to become a world-renowned biopharmaceutical company that is leading the way to conquering cancer.